Updated on 27 November 2025
AI Solutions in Digital Pathology
Professor - Head of Computer Vision Group at Yildiz Technical University - Computer Engineering Department
İstanbul, Türkiye
About
AI-based solutions in digital pathology like Tumor subtyping, Prognostic Scoring, Immune Response Analysis or Cellular and Tissue-level (tumor regions, stroma and immune cells) Annotation in Hematoxylin Eosin (HE) stained Whole Slide Images(WSI)
AI-powered diagnostic tools accepted as Software as a Medical Device (SaMD). Software as a Medical Device (SaMD) refers to standalone software that is intended for medical purposes without being part of a hardware medical device. It can be used for diagnosis, treatment, monitoring, or prevention of diseases. Our project idea is also a SAMD that Improves efficiency in pathology research and diagnostic workflows, enhances prognostic accuracy and supports personalized treatment decisions.
Topic
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-09: Multisectoral approach to tackle chronic non-communicable diseases: implementation research maximising collaboration and coordination with sectors and in settings beyond the healthcare system (GACD)
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
Type
- Partner seeks Consortium/Coordinator
Organisation
Similar opportunities
Project cooperation
- Partner seeks Consortium/Coordinator
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-09: Multisectoral approach to tackle chronic non-communicable diseases: implementation research maximising collaboration and coordination with sectors and in settings beyond the healthcare system (GACD)
Michal Podlucký
Grant Program Manager at POWERFUL MEDICAL s. r. o.
Bratislava, Slovakia
Project cooperation
Validated AI-based SAMD to Personalize Post-Hospital Care Pathways in Chronic Heart Failure
- Partner seeks Consortium/Coordinator
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
- DESTINATION 4: HORIZON-HLTH-2026-01-CARE-03: Identifying and addressing low-value care in health and care systems
Grégoire MERCIER
Co-founder at KanopyMed
Jacou, France
Project cooperation
Translational development of patient-centred health technologies
- Partner seeks Consortium/Coordinator
- DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
- DESTINATION 4: HORIZON-HLTH-2026-01-CARE-01: Public procurement of innovative solutions for improving citizens' access to healthcare through integrated or personalised approaches
Adara Castaño Barberá
Biomedical Engineer at Inbentus Medical Technology
Murcia, Spain